Jy. Park et al., PAST AND CURRENT OBESITY IN KOREANS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetes research and clinical practice, 35(1), 1997, pp. 49-56
To determine the prevalence of past and current obesity among patients
with non-insulin-dependent diabetes mellitus (NIDDM) and to define th
e clinical characteristics of non-obese NIDDM patients in South Korea,
we studied a cross-section of 749 NIDDM patients and a group of age-
and sex-matched control subjects. Current height, weight and waist-to-
hip ratio (WHR), the history of weight changes and the family history
of diabetes were recorded. Obesity was defined as body mass index (BMI
) > 25 kg/m(2). The maximum lifetime BMI of diabetic patients was sign
ificantly higher than that of control subjects (P < 0.001). Compared w
ith control subjects, current BMI was higher in diabetic women (P < 0.
001) but not in diabetic men. In contrast, WHR of both diabetic men an
d women were significantly higher than those of controls (P < 0.05). B
MI and WHR correlated significantly with fasting C-peptide levels and
log-triglyceride levels in NIDDM patients. As a whole, 72% of the Sout
h Korean NIDDM patients had a history of past obesity as assessed by t
heir maximum weight, while only 38% of them were currently obese. Comp
ared with obese patients, non-obese patients were characterized by low
er fasting serum C-peptide levels (P < 0.001), a higher percentage of
insulin treatment (P < 0.05), lower maximum BMI (P < 0.001) and more p
ronounced weight loss from the time at their maximum weight (P < 0.001
). In summary, increased upper body adiposity and a history of past ob
esity were associated with NIDDM in South Korea. Although most South K
orean NIDDM patients were previously obese, many of them were currentl
y not obese. Lower maximum BMI, lower serum C-peptide levels and a hig
her percentage of insulin treatment in non-obese NIDDM patients sugges
t that the capacity to increase insulin secretion in response to incre
asing weight gain is rather limited in these patients. (C) 1997 Elsevi
er Science Ireland Ltd.